Definitive Contract 75F40121C00157
Award Date
9/28/21
Potential Completion Date
2/28/23
Potential Value
$227K
Federal Agency
Food and Drug Administration
Awardee
University Of Florida
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $500,000 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research for a pharmacokinetic comparison study of locally acting orally inhaled drug products. The contract does not have a set-aside designation, indicating UF competed for and was awarded the contract based on its extensive research capabilities. UF is a major research institution that provides a wide range of goods and services to...
This federal contract award, identified as HHSF223201610099C, was made by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract, valued at $764,975.37, is for a Pharmacokinetic Comparison of Locally Acting Orally Inhaled Drug Products. This work falls under the FDA's Broad Agency Announcement (BAA) program for this research area. The contract is a definitive, cost-no-fee contract, with a performance period ending on March 22,...
The Department of Health and Human Services Food and Drug Administration awarded a $921,732.78 firm fixed-price definitive contract to the University of Florida's Division of Sponsored Research to conduct research on the "Systematic Evaluation of the Ex-Throat Plume Properties of MDI Formulations." The contract does not have any set-aside designation. As a public land-grant research university, the University of Florida has extensive experience providing research, development, testing,...
The U.S. Food and Drug Administration (FDA) awarded a $400,000.00 firm-fixed price contract to the Regents of the University of Michigan, Office of Research and Sponsored Projects (University of Michigan) to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development. This contract has a period of performance through March 31, 2026. The...
This contract was awarded by a U.S. government agency to the University of Florida, a public land-grant research university located in Gainesville, Florida. The contract, valued at $24,822.50, is for a basic research study under VAAR 873.104(a). It is a definitive, firm fixed-price contract with no set-aside designation. The University of Florida serves as the prime contractor, delivering educational and research services to the government, primarily in support of the Department of the Navy's...
This is a $85,150 firm-fixed-price delivery order awarded to the University of Florida Division of Sponsored Research by the U.S. Department of Veterans Affairs Veterans Integrated Service Network 8 for MRI support services. The award is not associated with a set-aside contract vehicle. The University of Florida is a major research institution that has received numerous federal contract and grant awards from agencies such as the Department of Defense, NASA, and USDA to conduct cutting-edge...
This is a $749,980 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) to develop a "TERATOGENIC RISK IMPACT AND MITIGATION (TRIM): AN EVIDENCE-BASED DECISION FRAMEWORK". The contract has no set-aside designation. UF, through its Division of Sponsored Research, will lead the effort which includes clinical expertise from a subcontractor, The Johns Hopkins University. This contract was awarded under the FDA's Broad Agency...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $245,000.00 firm fixed price purchase order to the University of Florida's Division of Sponsored Research for "Special Studies for COVID-19 Research." The contract does not have a small business or socioeconomic set-aside designation. As a public land-grant research university, the University of Florida has a history of providing research, technical, and professional services to various...
This is a $193,303 firm-fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to the University of Florida (UF) Division of Sponsored Research. The contract supports the National Health and Nutrition Examination Survey (NHANES) cohorts. The contract does not have a set-aside designation, indicating UF's ability to compete for and win the award based on its extensive research capabilities. UF, as a top-tier public land-grant research...
The University of Florida (UF) Division of Sponsored Research was awarded a Firm Fixed Price Delivery Order contract from the Office of Acquisitions and Grants, a civilian federal agency, with a ceiling value of $1,624. The contract, which does not have a set-aside designation, is for Task Order 8 under a larger Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID). This IDC, valued at $146.3 million over 7 years, supports the development and...